相关实验视频

Updated: May 1, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

在瑞士的年轻成年人中接种HPV疫苗:一个横截面研究

Samia El-Hadad¹, Maike Katja Sachs², Yara Barrense-Dias³

¹Department of Reproductional Endocrinology, Zurich University Hospital, Zurich, Switzerland samia.el-hadad@usz.ch.

|February 12, 2025

概括

在瑞士的年轻人中,特别是男性中,人乳头瘤病毒 (HPV) 疫苗接种率较低,原因是缺乏信息和对益处的认识. 需要有针对性的干预措施来改善HPV疫苗的覆盖率.

科学领域:

公共卫生公共卫生
疫苗学疫苗学疫苗学
流行病学流行病学

背景情况:

人类乳头瘤病毒 (HPV) 感染是一个重大的全球健康问题,主要是通过性传播传播,并与各种癌症有关.
针对HPV的疫苗接种是预防的关键策略,但接种率在不同人群和性别之间有很大差异.

研究的目的:

评估HPV疫苗接种情况和瑞士年轻成年人中的接种疫苗.
在男性和女性年轻成年人中确定与HPV疫苗接种相关的社会人口和行为因素.

主要方法:

2017年对7142名参与者进行了一项代表性的跨部门在线调查.
对来自2155名女性和996名男性的数据进行了统计分析,包括双变量和多变量回归.

主要成果:

女性的HPV疫苗接种率为40.9%,男性为7.8%,缺乏信息是男性的关键障碍.
不接种疫苗的原因包括对疫苗的犹和缺乏感知益处.
与疫苗接种相关的因素因性别而异,包括社会经济地位和性行为.

结论:

较低的HPV疫苗接种率,特别是在男性中,与缺乏关于疫苗益处的知识有关.
迫切需要改进公共卫生信息和有针对性的干预措施,以增加年轻人的HPV疫苗接种范围.
在医疗保健咨询期间,澄清疫苗接种情况和讨论益处至关重要.

关键词:

跨部门研究跨部门研究在HPV疫苗的使用中.疫苗接种疫苗接种

更多相关视频

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 12, 2014

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...